U.S. And Allies To Block Some Russian Banks From SWIFT

U.S. And Allies To Block Some Russian Banks From SWIFT

WASHINGTON/BRUSSELS (Reuters) – The United States, Britain, Europe and Canada on Saturday moved to block certain Russian banks’ access to the SWIFT international payment system as part of more sanctions against Moscow as it continues its assault against Ukraine. The measures, which will also include restrictions on the Russian central bank’s international reserves, will be…

Read More

‘California is meant to burn’: Experts teach landowners art of prescribed burns

By Nathan Frandino GEORGETOWN, California (Reuters) – The prescribed burn begins on a California hill with a drip torch to light brush, needles and fallen branches, the flames spreading out on the forest floor far below the tree canopy. Students on this Saturday class learn how to keep the burn under control, while others stand…

Read More
U.S. Seeks To Prevent China From Benefiting From $52 Billion Chips Funding

U.S. Seeks To Prevent China From Benefiting From $52 Billion Chips Funding

By David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department on Tuesday released proposed rules to prevent $52 billion in semiconductor manufacturing and research funding from being used by China and other countries deemed of concern. The proposal limits recipients of U.S. funding from investing in the expansion of semiconductor manufacturing in foreign countries of concern…

Read More

As counteroffensive looms, Ukraine vows not to give up Bakhmut

By Olena Harmash KYIV (Reuters) -Ukraine’s military vowed on Tuesday not to give up the pulverised eastern city of Bakhmut as it prepares to launch a long-promised counteroffensive against Russian forces. General Oleksandr Syrskyi, commander of ground forces, underlined the importance Kyiv attaches to holding Bakhmut as preparations continue for a counterattack which it hopes…

Read More

GSK’s RSV vaccine shows long-term efficacy in late-stage trial

(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults in a late-stage trial. The British drugmaker said a ‘Phase III’ trial showed vaccine efficacy against RSV-lower respiratory tract disease and severe disease over two full RSV seasons, including in…

Read More
After Rocky Period, U.S. Stocks Will End Year Up From Current Levels: Reuters Poll

After Rocky Period, U.S. Stocks Will End Year Up From Current Levels: Reuters Poll

By Caroline Valetkevitch NEW YORK (Reuters) – Wall Street strategists expect U.S. stocks to end 2022 above current beaten-down levels but some warned of turbulence on concerns inflation and aggressive interest rate rises crimps economic growth and unnerves investors, a Reuters poll found. The benchmark S&P 500 will end this year at 4,400, based on…

Read More